Administer orally, preferably at the start of a meal to minimize potential gastrointestinal intolerance. Shake the bottle well before each use and use the provided measuring device.

Amoxicillin inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs). Clavulanic acid is a beta-lactamase inhibitor that irreversibly binds to and inactivates beta-lactamase enzymes produced by bacteria, thus protecting amoxicillin from degradation.

• •History of hypersensitivity to penicillin or other beta-lactam antibiotics (e.g., cephalosporins)
• •History of amoxicillin/clavulanic acid-associated jaundice or hepatic dysfunction
• •Infectious mononucleosis

Store the dry powder below 25°C in a dry place, away from direct sunlight. After reconstitution, store the suspension in a refrigerator (2-8°C) and discard any unused portion after 7-14 days.

Overdose may lead to gastrointestinal symptoms (e.g., abdominal pain, vomiting, diarrhea) and fluid/electrolyte imbalance. Renal dysfunction, crystalluria, and convulsions can also occur. Treatment is symptomatic and supportive. Hemodialysis can remove amoxicillin/clavulanic acid from circulation.

Pregnancy Category B. Should be used during pregnancy only if clearly needed. Both amoxicillin and clavulanic acid are excreted into breast milk. Generally considered compatible with breastfeeding, but caution is advised. Monitor infant for potential adverse effects like diarrhea, candidiasis, or skin rash.